港股異動丨華住集團盤初升超5%
華住集團-S(1179.HK)盤初升超5%報28.55港元。隔夜美股華住收升4.07%報36.58美元,折算成港股市場價格為28.58港元/股。公司此前發佈業績顯示,Q3實現收入62.88 億元/同比+53.6%;實現歸母淨利潤13.37 億元(去年同期為虧損7.17 億元),環比二季度,公司收入、利潤持續恢復,收入增速超先前指引。另外,華住集團將於2023年12月15日除權除息,1股派股息0.48326HKD,1股派特別股息0.24163HKD。相關派息股權登記日為2023年12月18日,除淨日為2023年12月15日,派息日為2024年1月10日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.